6505--Intent to Sole Source | 5 Year Consolidated Contract Indefinite Delivery/Indefinite Quanity | Radiopharm Xofigo, Illucix, Netspot | Lebanon, Pittsburgh, Philadelphia VA Medical Centers
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 4 (NCO4), intends to sole source a five-year consolidated contract for Ga-68 Netspot, Ga-68 Illucix, and Ra-223 Xofigo Radiopharmaceuticals. These radiopharmaceuticals are for the Lebanon, Philadelphia, and VA Pittsburgh Healthcare Systems. The VA plans to negotiate this Firm Fixed-Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract with Cardinal Health, 414, LLC. Interested vendors must submit a capability statement by February 10, 2026, at 10:00 AM EST.
Opportunity Details
This is a Special Notice of Intent to Sole Source under the authority of FAR 6.103-11 (Single Source Justification). It is for planning purposes only and is not a request for quotations; no solicitation will be made available. The government reserves the right to proceed with the sole source negotiation if no viable responses are received.
Scope of Work
The contractor will provide timely delivery and continuous inventory management of name-brand only radiopharmaceuticals: Xofigo (Radium 223 dichloride), Illucix (Gallium 68 PSMA-11), and NETSPOT (Gallium 68 Dotatate). A critical requirement is that the distributor must be located within the Pittsburgh, Philadelphia, and Lebanon areas due to the 68-minute half-life of these products. Key responsibilities include:
- Providing barcode-labeled inserts compatible with Nuclear Medicine Information Systems (NMIS).
- Performing all required quality control procedures prior to shipment.
- Complying with all Federal and State regulations (NRC, DOT, FDA, OSHA, HIPAA).
- Holding current NRC and FDA licenses for radiopharmaceutical production and distribution.
- Providing evidence of special driver's licenses for hazardous materials transport.
- Accepting returns for credit under specified conditions and replacing defective products within three hours.
- Providing miscellaneous supplies/services such as OSHA compliant monitoring devices and calibrator calibration.
Contract & Timeline
- Contract Type: Firm Fixed-Price, Indefinite Delivery/Indefinite Quantity (IDIQ).
- Period of Performance: Five years, anticipated from April 1, 2026, through March 31, 2031.
- NAICS Code: 325412 (Pharmaceutical and Medicine Manufacturing).
- SBA Size Standard: 1300 employees.
Submission Requirements
Interested vendors capable of meeting this requirement must submit a capability statement (no more than one page) via email to the Contracting Specialist. The statement must include:
- Company Name
- UEI SAM Number
- Socioeconomic Category
- Brief description of business capability to handle this project at the specified VA Medical Centers.
Evaluation & Next Steps
Responses will be evaluated to determine if competition is feasible. However, the government retains sole discretion not to compete the procurement. If no responses are received, the VA will proceed with the sole source negotiation with Cardinal Health, 414, LLC.
Key Dates & Contact
- Capability Statement Due: February 10, 2026, by 10:00 AM EST.
- Contact: Christa Stine, Contract Specialist, christa.stine@va.gov, 570-824-3521.